Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 10,000 shares at $40.22 ($392K) on 2014-04-01, disclosed to the SEC on 2014-04-02.
Scheduled sale ($392k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.92 | 8,200 | $319K | 81.5% |
| 2 | $40.22 | 1,600 | $64K | 16.4% |
| 3 | $40.70 | 200 | $8K | 2.1% |
| Total | $39.16 avg | 10,000 | $392K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $23K | — | Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |